Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
ACS Infectious Diseases|October 11, 2023
Small-Molecule Antibiotic Drug Development: Need and ChallengesMegan Bergkessel, Barbara Forte, Ian H Gilbert
Cellular and Molecular Life Sciences : CMLS|March 14, 2016
Dissecting the role of microRNAs in prostate cancer metastasis: implications for the design of novel therapeutic approachesValentina Doldi, Marzia Pennati, Barbara Forte, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|June 30, 2009
A straightforward total synthesis of (-)-chaetominineBeatrice Malgesini, Barbara Forte, Daniela Borghi, et al.
Marine Drugs|January 26, 2010
A submarine journey: the pyrrole-imidazole alkaloidsBarbara Forte, Beatrice Malgesini, Claudia Piutti, et al.
Expert Opinion on Therapeutic Patents|September 12, 2009
Poly(ADP-ribose) polymerase inhibition in cancer therapy: are we close to maturity?Gianluca Papeo, Barbara Forte, Paolo Orsini, et al.
Frontiers in Cell and Developmental Biology|July 5, 2022
MIR205HG/LEADR Long Noncoding RNA Binds to Primed Proximal Regulatory Regions in Prostate Basal Cells Through a Triplex- and Alu-Mediated MechanismEugenia Bezzecchi, Giulia Pagani, Barbara Forte, et al.
Nucleic Acids Research|April 22, 2021
Mycobacterium tuberculosis Phe-tRNA synthetase: structural insights into tRNA recognition and aminoacylationKarolina Michalska, Robert Jedrzejczak, Jacek Wower, et al.
Nature Communications|January 20, 2019
LEADeR role of miR-205 host gene as long noncoding RNA in prostate basal cell differentiationValentina Profumo, Barbara Forte, Stefano Percio, et al.
Bioorganic & Medicinal Chemistry Letters|April 8, 2011
NMS-P937, a 4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline derivative as potent and selective Polo-like kinase 1 inhibitorItalo Beria, Roberto T Bossi, Maria Gabriella Brasca, et al.
Pageof 3